Stock Report

Rossari Biotech Ltd Q4FY25 consolidated profit up at Rs. 34.44 crores

Posted On : 2025-04-26 00:37:29( TIMEZONE : IST )

Rossari Biotech Limited has reported Consolidated financial results for the period ended March 31, 2025.

Financial Results (Q4 FY2025) - QoQ Comparison

The company has reported total income of Rs. 581.353 crores during the period ended March 31, 2025 as compared to Rs. 513.282 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs. 34.444 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 31.702 crores for the period ended December 31, 2024.

The company has reported EPS of Rs. 6.21 for the period ended March 31, 2025 as compared to Rs. 5.72 for the period ended December 31, 2024.

Financials	Q4 FY2025	Q3 FY2025	% Change
Total Income	₹ 581.353 crs	₹513.282 crs	13.26%
Net Profit	₹34.444 crs	₹31.702 crs	8.65%
EPS	₹6.21	₹5.72	8.57%

Financial Results (Q4 FY2025) - YoY Comparison

The company has reported total income of Rs. 581.353 crores during the period ended March 31, 2025 as compared to Rs.473.105 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs.34.444 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.34.132 crores for the period ended March 31, 2024.

The company has reported EPS of Rs.6.21 for the period ended March 31, 2025 as compared to Rs.6.17 for the period ended March 31, 2024.

Financials	Q4 FY2025	Q4 FY2024	% Change
Total Income	₹ 581.353 crs	₹473.105 crs	22.88%
Net Profit	₹34.444 crs	₹34.132 crs	0.91%
EPS	₹6.21	₹6.17	0.65%

Financial Results (Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.2084.303 crores during the Financial Year ended March 31, 2025 as compared to Rs.1838.004 crores during the Financial Year ended March 31, 2024.

The company has posted net profit / (loss) of Rs.136.378 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.130.689 crores for the Financial Year ended March 31, 2024.

The company has reported EPS of Rs.24.63 for the Financial Year ended March 31, 2025 as compared to Rs.23.62 for the Financial Year ended March 31, 2024.

Financials	Year Ended FY2025	Year Ended FY2024	% Change
Total Income	₹2084.303 crs	₹1838.004 crs	13.40%
Net Profit	₹136.378 crs	₹130.689 crs	4.35%
EPS	₹24.63	₹23.62	4.28%

Shares of Rossari Biotech Limited was last trading in BSE at Rs. 698.80 as compared to the previous close of Rs. 704.60. The total number of shares traded during the day was 11633 in over 1146 trades.

The stock hit an intraday high of Rs. 715.00 and intraday low of 684.60. The net turnover during the day was Rs. 8113172.00.